High Dose Pharmaceutical Grade Biotin (MD1003) Accelerates Differentiation of Murine and Grafted Human Oligodendrocyte Progenitor Cells In Vivo
Accumulating evidences suggest a strong correlation between metabolic changes and neurodegeneration in CNS demyelinating diseases such as multiple sclerosis (MS). Biotin, an essential cofactor for five carboxylases, is expressed by oligodendrocytes and involved in fatty acid synthesis and energy pro...
Main Authors: | Marion J. F. Levy, Beatriz Garcia-Diaz, Frédéric Sedel, Anne Baron-Van Evercooren, Sabah Mozafari |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-12-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/23/24/15733 |
Similar Items
-
Ultrastructural Characterization of Human Oligodendrocytes and Their Progenitor Cells by Pre-embedding Immunogold
by: María J. Ulloa-Navas, et al.
Published: (2021-06-01) -
Generation of Oligodendrocyte Progenitor Cells From Mouse Bone Marrow Cells
by: Yuan Zhang, et al.
Published: (2019-06-01) -
Premyelinating Oligodendrocytes: Mechanisms Underlying Cell Survival and Integration
by: Ethan G. Hughes, et al.
Published: (2021-07-01) -
Metabolomics Profile of the Secretome of Space-Flown Oligodendrocytes
by: Laurent Vergnes, et al.
Published: (2023-09-01) -
Biomarkers of treatment response in patients with progressive multiple sclerosis treated with high‐dose pharmaceutical‐grade biotin (MD1003)
by: Nicolas Collongues, et al.
Published: (2021-02-01)